The main finding of this study is that all samples with SOX1-abs determined with the commercial line blot and confirmed by TBA were also positive by CBA and associated with lung cancer (100%) and definite diagnosis of PNS (88%). The gene discussed is SOX1; the disease is lung carcinoma.